Commentary: Obesity: The "Achilles heel" for COVID-19?

Giovanna Muscogiuri, Gabriella Pugliese, Luigi Barrea, Silvia Savastano, Annamaria Colao, Giovanna Muscogiuri, Gabriella Pugliese, Luigi Barrea, Silvia Savastano, Annamaria Colao

No abstract available

Keywords: COVID-19; Coronavirus; Obesity; Pneumonia.

Conflict of interest statement

Declaration of competing interest All authors declare no conflict of interests.

References

    1. Simonnet A., Chetboun M., Poissy J., Raverdy V., Noulette J., Duhamel A. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020 Apr 9 doi: 10.1002/oby.22831.
    1. Dhurandhar N.V., Bailey D., Thomas D. Interaction of obesity and infections. Obes Rev. 2015;16:1017–1029. doi: 10.1111/obr.12320.
    1. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr. 2010;140:1691–1697. doi: 10.3945/jn.110.123653.
    1. Vieira Potter V.J. Inflammation and macrophage modulation in adipose tissues. Cell Microbiol. 2014;16:1484–1492. doi: 10.1111/cmi.12336.
    1. Park H.S., Park J.Y., Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69:29–35. doi: 10.1016/j.diabres.2004.11.007.
    1. Hagau N., Slavcovici A., Gonganau D.N., Oltean S., Dirzu D.S., Brezoszki E.S. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 2010;14:R203. doi: 10.1186/cc9324.
    1. Chen C., Zhang X.R., Ju Z.Y., He W.F. Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi. 2020;36 doi: 10.3760/cma.j.cn501120-20200224-00088.
    1. Stroud C.R., Hegde A., Cherry C., Naqash A.R., Sharma N., Addepalli S. Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. J Oncol Pharm Pract. 2019;25:551–557. doi: 10.1177/1078155217745144.
    1. Klonoff D.C., Umpierrez G.E. COVID-19 in patients with diabetes: risk factors that increase morbidity. Metabolism. 2020 Apr;7:154224. doi: 10.1016/j.metabol.2020.154224.
    1. Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8 doi: 10.1016/S2213-2600(20)30116-8.
    1. Rabec C., de Lucas Ramos P., Veale D. Respiratory complications of obesity. Arch Bronconeumol. 2011;47:252–261. doi: 10.1016/S1579-2129(11)70061-1.
    1. Eslam M., Newsome P.N., Anstee Q.M., Targher G., Gomez M.R., Zelber-Sagi S. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020 Apr 8 doi: 10.1016/j.jhep.2020.03.039. pii: S0168-8278(20)30201-4.
    1. Van der Poorten D., Milner K.L., Hui J., Hodge A., Trenell M.I., Kench J.G. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449–457. doi: 10.1002/hep.22350.
    1. Zheng K.I., Gao F., Wang X.B., Sun Q.F., Pan K.H., Wang T.Y., Ma H.L., Liu W.Y., George J., Zheng M.H. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism. 2020 Apr 19:154244. doi: 10.1016/j.metabol.2020.154244. [Epub ahead of print] PubMed PMID: 32320741; PubMed Central PMCID: PMC7166301.
    1. Magro C., Mulvey J., Berlin D., Nuovo G., Salvatore S., Harpe J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. April 2020 doi: 10.1016/j.trsl.2020.04.007.
    1. Bouillon R., Marcocci C., Carmeliet G. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40:1109–1151. doi: 10.1210/er.2018-00126.
    1. Martineau A.R., Jolliffe D.A., Hooper R.L. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi: 10.3310/hta23020.
    1. Isaia G., Giorgino R., Rini G.B. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int. 2003;14:577–582. doi: 10.1007/s00198-003-1390-7.
    1. Formenti A.M., Tecilazich F., Frara S. Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism. Endocrine. 2019;66:699–700. doi: 10.1007/s12020-019-02105-6.
    1. Grant W.B., Lahore H., McDonnell S.L. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12 doi: 10.3390/nu12040988. pii: E988.
    1. Ying-Hui J., Lin C., Zhen-Shun C. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia. Mil Med Res. 2020;7:4. doi: 10.1186/s40779-020-0233-6.
    1. Torres-Fuentes C., Schellekens H., Dinan T.G. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol. 2017;2:747–756. doi: 10.1016/S2468-1253(17)30147-4.
    1. Rebelos E., Moriconi D., Virdis A., Taddei S., Foschi D., Nannipieri M. Importance of metabolic health in the era of COVID-19. Metabolism. 2020 Apr 22:154247. doi: 10.1016/j.metabol.2020.154247. [Epub ahead of print] PubMed PMID: 32333939.
    1. Muscogiuri G., Barrea L., Savastano S., Colao A. Nutritional recommendations for CoVID-19 quarantine. Eur J Clin Nutr. 2020 Apr 14 doi: 10.1038/s41430-020-0635-2.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する